Division of Pathology, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, 6-5-1, Kashiwanoha, Kashiwa-City, Chiba 277-8577, Japan; Departments of General Thoracic Surgery, Juntendo University School of Medicine, 1-3, Hongo 3 cho-me, Bunkyo-ku, Tokyo 113-8431, Japan; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa-City, Chiba 277-8577, Japan.
Division of Pathology, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, 6-5-1, Kashiwanoha, Kashiwa-City, Chiba 277-8577, Japan; Departments of General Thoracic Surgery, Juntendo University School of Medicine, 1-3, Hongo 3 cho-me, Bunkyo-ku, Tokyo 113-8431, Japan; Department of Thoracic Surgery, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa-City, Chiba 277-8577, Japan.
Lung Cancer. 2018 Jan;115:56-63. doi: 10.1016/j.lungcan.2017.11.013. Epub 2017 Nov 20.
Carbonic anhydrase IX (CAIX) is a marker of hypoxia and its expression by cancer associated fibroblasts (CAFs) was reportedly associated with the poor prognosis of lung adenocarcinoma. This study aimed to characterize the hypoxic microenvironment containing CAIX (+) CAFs.
First, we evaluated the clinicopathological significance of CAIX expression by CAFs in 3cm and above lung adenocarcinoma (n=188). We then compared the expressions of E-cadherin, ezrin, ALDH-1, CD44, EGFR, HSF-1, Glut-1, and PD-L1 in cancer cells, as well as those of CD204 and podoplanin in stromal cells between CAIX (+) CAFs and CAIX (-) CAFs cases (n=25, each).
In total, 48 patients had CAIX (+) CAFs (26%). Multivariate analysis revealed that CAIX expression by CAFs could serve as an independent unfavorable prognostic factor for recurrence-free survival (p<0.05). The staining score of hypoxia marker Glut-1 in cancer cells was significantly higher in cases with CAIX (+) CAFs than in those with CAIX (-) CAFs (median: 20 vs. 0, p<0.01). In addition, the numbers of CD204 (+) tumor-associated macrophages (TAMs) and podoplanin (+) CAFs were significantly higher in the CAIX (+) CAFs group than in the CAIX (-) CAFs group (TAMs: 31.5 vs. 17.0: p<0.01, CAFs: 20 vs. 0: p<0.05). The staining score of the other markers did not differ between the groups.
Our results indicate that the presence of abundant tumor promoting stromal cells, CD204 (+) TAMs, and podoplanin (+) CAFs is characteristic of the tumor microenvironment containing CAIX (+) CAFs, which contributes to an increase in aggressive behavior in lung adenocarcinoma with hypoxic regions.
碳酸酐酶 IX(CAIX)是缺氧的标志物,据报道,其在癌相关成纤维细胞(CAFs)中的表达与肺腺癌的不良预后相关。本研究旨在描述富含 CAIX(+)CAFs 的缺氧微环境。
首先,我们评估了 3cm 以上肺腺癌(n=188)中 CAFs 中 CAIX 表达的临床病理意义。然后,我们比较了 CAIX(+)CAFs 与 CAIX(-)CAFs 病例(n=25,各)中癌细胞中 E-钙黏蛋白、ezrin、ALDH-1、CD44、EGFR、HSF-1、Glut-1 和 PD-L1 的表达,以及基质细胞中 CD204 和 podoplanin 的表达。
共有 48 例患者存在 CAIX(+)CAFs(26%)。多因素分析显示,CAFs 中 CAIX 的表达可作为无复发生存的独立不良预后因素(p<0.05)。CAIX(+)CAFs 病例中癌细胞的缺氧标志物 Glut-1 染色评分明显高于 CAIX(-)CAFs 病例(中位数:20 与 0,p<0.01)。此外,CAIX(+)CAFs 组的 CD204(+)肿瘤相关巨噬细胞(TAMs)和 podoplanin(+)CAFs 数量明显高于 CAIX(-)CAFs 组(TAMs:31.5 与 17.0:p<0.01,CAFs:20 与 0:p<0.05)。两组之间其他标志物的染色评分无差异。
我们的结果表明,富含肿瘤促进基质细胞、CD204(+)TAMs 和 podoplanin(+)CAFs 的存在是富含 CAIX(+)CAFs 的肿瘤微环境的特征,这有助于增加富含缺氧区的肺腺癌的侵袭性行为。